6 TECH OUTLOOKMAY - 2021EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comEven though the digitalization of clinical trials was already underway, last year's COVID-19 pandemic has undoubtedly expedited the paradigm shift. Virtual trials, remote monitoring, and wearables have all now become integral parts of e-clinical trial management. In that sense, COVID-19 is the catalyst clinical trial industry needed to take a long hard look at itself, and now that we've proved it's possible, there is no going back. This years' unique healthcare environment also offers enormous opportunities for clinical trial sites, but only if they carefully evaluate their business needs and deploy solutions that maximize their readiness to act upon them.Clinical trial sites must develop more innovative tools and techniques to digitize records, enhance patient support, and deliver value to sponsors in this environment. This also brings these sites closer to the use of blockchain technology. This is one of the latest technologies to have the least exposure so far. But as clinical trial sites double down on peer-to-peer systems to increase their recruitment and retention efforts, it will push them to leverage blockchain technologies all the more.In this edition of Pharma Tech Outlook, we bring you the story of some of the most prominent organizations specializing in best-of-breed e-clinical trial management solutions and are significant drivers of key trends and strategies. Besides, the magazine also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CXOs. We hope this edition will provide you with the right assistance in choosing the best e-clinical trial management solutions and services provider according to your requirements.Let us know your thoughts!Propelling e-Clinical Trials beyond the ThresholdCopyright © 2021 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY - 10 - 2021, Vol 07 - Issue 03 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comsales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:John GothamTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >